Hematinics Market Growth Projected to Register a CAGR of 8.6% Between 2023- 2031: Growth Plus Reports Study


Newark, New Castle, USA, April 27, 2023 (GLOBE NEWSWIRE) — The global Hematinics Market is expected to register a revenue CAGR of 8.6%, according to a new Growth Plus Reports research. The research looks at key tactics, trends and potential, competition, evolving industry dynamics, market size, statistics and projections, and key investment territories.

Key Takeaways:

  • The increasing prevalence of anemia will drive market revenue growth.
  • Increasing awareness of the advantages of hematinics will drive demand for hematinics.
  • North America dominates the global hematinics market. 


Download PDF Brochure on Hematinics Market Size – COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.growthplusreports.com/inquiry/request-sample/hematinics-market/8628

                                                Hematinics Market Scope

Report Attribute Details
Growth Rate CAGR of 8.6% from 2023 to 2031
Base Year for Estimation 2022
Forecast Period 2023-2031
Historical Year 2021
Segments Covered Route of Administration, Drug Type, Application, Distribution Channel, and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Market Drivers
The increasing prevalence of anemia and other hemoglobin-related diseases will drive the revenue growth of hematinics market. Furthermore, the improved healthcare infrastructure, growing demand for personalized medicine methods, development of non-invasive hematinic administration systems, and enhanced patient outcomes and convenience are expected to boost the market revenue growth rate. Apart from this, the rising awareness of the advantages of hematinics, as well as increased demand for combination products containing several hematinic substances are expected to support the market’s revenue growth.

Market Segmentation
Growth Plus Reports has analyzed global hematinics market from five perspectives: Route of Administration, Drug Type, Application, Distribution Channel, and Region.

Route of Administration Segmentation: Based on the route of administration, the global hematinics market is segmented into oral and parenteral. The oral route of administration segment dominates the market with the largest revenue share because it provides a high level of convenience because they may be taken without medical help, making them more user-friendly, and are less expensive than other types.

Drug Type Segmentation: Based on the drug type, the global hematinics market is segmented into iron supplements, maturation factors, and erythropoietin. The iron supplements segment dominates the market with the largest revenue share because iron-based hematinics are highly effective in increasing hemoglobin levels and treating iron deficiency anemia, and are available in a variety of forms, including tablets, capsules, injections, and infusions, allowing for greater treatment flexibility and catering to a broader patient population.

Application Segmentation: Based on the application, the global hematinics market is segmented into iron deficiency anemia, chronic kidney disease related anemia, inflammatory bowel disease related anemia, cancer related anemia and others. The iron deficiency anemia segment dominates the market because it is the most common kind of anemia, affecting a large percentage of the population, especially women and children.

Distribution Channel Segmentation: Based on the distribution channel, the global hematinics market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment dominates the market because hematinics are frequently prescribed to hospitalized patients, particularly those who have had surgery or who are suffering from chronic diseases, and hospital pharmacies are the primary source of medicine for such patients.

Regional Growth Dynamics
Based on the region, the global hematinics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America dominates the global hematinics market with the largest revenue share of the market. The growing prevalence of iron deficiency anemia, technological advances in healthcare, increased hematology research and development, the development of new and innovative hematinics products, and the advanced healthcare infrastructure are the major factors responsible for North America’s significant revenue share in the global market.  

Request for Customization – https://www.growthplusreports.com/inquiry/customization/hematinics-market/8628

Competitive Landscape

Some key players operating in the global hematinics market are:

  • Pfizer Inc.
  • Sanofi S.A.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Amgen, Inc.
  • Johnson & Johnson Services, Inc.
  • F. Hoffmann-La Roche Ltd.

The hematinics market is somewhat competitive with a number of global corporations. Leading players invest in technological advancements, research and development, and mergers and acquisitions to strengthen their market position.

Table of Content

    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources 
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022)
    3. Regulatory Landscape 
    4. Reimbursement scenario 
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
    1. Oral
    2. Parenteral
    1. Iron Supplements 
    2. Maturation Factors
      1. Vitamin B12 
      2. Folic Acid
    3. Erythropoietin


Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8628


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse Latest Healthcare Related Reports:

IVD Contract Manufacturing Market by Type (IVD Consumables, IVD Equipments), by Services (Assay Development Services, Manufacturing Services, Others), Technology (Immunoassay, Clinical Diagnostics) – Global Outlook & Forecast 2023 -2031

Polypectomy Snares Market by Type (Cold Polypectomy Snares and Hot Polypectomy Snares), End User (Hospitals, Ambulatory Surgery Centers) – Global Outlook & Forecast 2023-2031

Golimumab Market by Indications (Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), – Global Outlook and Forecast 2023-2031

Eosinophilic Fasciitis Market by Drug Class (Corticosteroids, Immunosuppressants), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook and Forecast 2023-2031

Thymidine Phosphorylase Inhibitors Market by Application (Metastatic Colorectal Cancer, Gastric Cancer), Distribution Channel (Retail Pharmacies, Hospital Pharmacies) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020”.

CONTACT: Manan Sethi Director, Market Insights Email: [email protected] 256 Chapman Road STE 105-4, Newark, New Castle - 19702, USA Phone no: +1 888 550 5009 Web: https://www.growthplusreports.com/  

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.